Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2994 USD | +6.51% | +12.30% | -87.31% |
May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.67M | Capitalization | 19.3M |
---|---|---|---|---|---|
Net income 2024 * | -40M | Net income 2025 * | -41M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.22 x |
P/E ratio 2024 * |
-0.48
x | P/E ratio 2025 * |
-0.6
x | Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on GlycoMimetics, Inc.
1 day | +6.51% | ||
1 week | +12.30% | ||
Current month | -83.37% | ||
1 month | -86.14% | ||
3 months | -90.70% | ||
6 months | -79.35% | ||
Current year | -87.31% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 59 | 18-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.2994 | +6.51% | 2,713,268 |
24-05-16 | 0.2811 | +4.11% | 912,727 |
24-05-15 | 0.27 | -2.17% | 1,225,277 |
24-05-14 | 0.276 | +5.18% | 1,687,635 |
24-05-13 | 0.2624 | -1.58% | 1,484,856 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.31% | 19.3M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- GLYC Stock